These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 23597106)

  • 1. Combined antiplatelet therapy: still a sweeping combination in cardiology.
    Manolis AS; Manolis TA; Papadimitriou P; Koulouris S; Melita H
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):136-67. PubMed ID: 23597106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and clopidogrel: a sweeping combination in cardiology.
    Manolis AS; Tzeis S; Andrikopoulos G; Koulouris S; Melita H
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):203-19. PubMed ID: 15974885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].
    Drouet L; Bal dit Sollier C; Henry P
    Drugs; 2010 Nov; 70 Suppl 1():9-14. PubMed ID: 20977287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple antiplatelet therapy in acute coronary syndromes.
    Valgimigli M; Minarelli M
    Drugs; 2011 Sep; 71(13):1703-19. PubMed ID: 21902293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of clopidogrel.
    Sarafoff N; Byrne RA; Sibbing D
    Curr Pharm Des; 2012; 18(33):5224-39. PubMed ID: 22724411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel and risk for acute coronary events.
    Mood GR; Bhatt DL
    Curr Atheroscler Rep; 2007 Nov; 9(5):401-8. PubMed ID: 18001624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.
    Coccheri S
    Drugs; 2010 May; 70(7):887-908. PubMed ID: 20426498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in antiplatelet agents used in cardiovascular diseases.
    Cheng JW
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report.
    Chyrchel B; Totoń-Żurańska J; Kruszelnicka O; Chyrchel M; Mielecki W; Kołton-Wróż M; Wołkow P; Surdacki A
    Platelets; 2015; 26(6):593-7. PubMed ID: 25350775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Clopidogrel in 2020: A Reappraisal.
    Patti G; Micieli G; Cimminiello C; Bolognese L
    Cardiovasc Ther; 2020; 2020():8703627. PubMed ID: 32284734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.
    Tourmousoglou CE; Rokkas CK
    Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):312-22. PubMed ID: 18855644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel: how good is it and how does it work?
    Santa-Cruz RA; Steinhubl SR
    Curr Cardiol Rep; 2004 Jul; 6(4):264-8. PubMed ID: 15182601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Mehta SR; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
    Galli M; Franchi F; Rollini F; Been L; Jaoude PA; Rivas A; Zhou X; Jia S; Maaliki N; Lee CH; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Geisler T; Jennings LK; Bass TA; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):728-737. PubMed ID: 35353154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.